Gavi signs agreements with Sinopharm and Sinovac for immediate supply to COVAX

Unitaid statement on WHO recommendations for tocilizumab and sarilumab

Joint COVAX Statement on the equal recognition of vaccines

6 million children benefitting from the first ever multi-antigen vaccination campaign

Harare, 1 July 2021 – UNICEF, Gavi, the Vaccine Alliance and […]

Gavi signs agreement with Clover Biopharmaceuticals for supply to COVAX

Indonesia introduces Pneumococcal Conjugate Vaccine (PCV) across the country

  • Gavi, UNICEF and partners collaborate on nationwide introduction, which […]

Gavi Board strengthens commitment to reaching the most vulnerable through routine immunisation and COVAX

  • Gavi Board makes key strategic decisions to support Gavi’s […]

Gavi and the Global Fund sign groundbreaking agreement with International Federation of Accountants to support in-country financial management

  • Geneva, 24 June 2021 – Global health leaders Gavi, the […]

What does COVAX’s latest supply forecast tell us?

23 June 2021 – by Aurélia Nguyen, Managing Director, Office of […]

Unitaid’s Executive Board meets to discuss strategic direction in an evolving global health landscape at 38th meeting